Q1 Earnings Estimate for OKUR Issued By Leerink Partnrs
OnKure Therapeutics (NASDAQ:OKUR – Free Report) – Analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of OnKure Therapeutics in a research note issued to investors on Monday, April 28th. Leerink Partnrs analyst A. Berens expects that the company will post earnings per share of ($1.22) for the quarter. […]
